Biography/Memoir

No… settlement… opioid claims… [and Sackler family]

[The Department of Justice is fighting to strip the billionaire Sackler family of the sweeping legal immunity… according to Forbes, the Sackler family made $12 billion to $13 billion in profit from OxyContin manufacturer Purdue Pharma – much more than what was previously known, according to the Wall Street Journal, citing court records.] [Attorney General Merrick Garland said in a statement he was pleased… “The bankruptcy court did not have the authority to deprive victims of the opioid crisis of their right to sue the Sackler family.”] [“Greed is the main thing. The market for OxyContin should have been much, much smaller, but they wanted to have a $10bn [+] drug and they didn’t tell the truth about their product,” Stanford University ethics professor Rob Reich added.]

U.S. Bankruptcy Judge Robert Drain Drain gave the parties a deadline of Wednesday [2/16/2022] to reach an agreement. They didn’t get there… [Drain then] extended until March 3 [2022] legal protections for the company and its owners that had been set to expire… a group of seven… U.S. senators this week sent a letter to the U.S. Department of Justice to call for criminal charges against Sackler family members to be considered… attorneys general for eight states and the District of Columbia… contending the deal didn’t do enough to hold the Sacklers accountable… after the bankruptcy judge [Drain] approved the deal… prevailed on appeal, persuading [Judge Colleen McMahon’s] last December [2021] to reject the settlement by ruling that bankruptcy courts could not provide legal protections to parties not in bankruptcy if others objected. That ruling prompted a new round of mediation with hundreds of hours of meetings… the company and the… attorneys general representing California, Connecticut, Delaware, the District of Columbia, Maryland, Oregon, Rhode Island, Vermont and Washington state…

Original Article (ABC):
No new settlement yet of opioid claims against Purdue Pharma
Artwork Fair Use: Till Niermann

Biography/Memoir

…launch of…